Bank of Nova Scotia Sells 95,862 Shares of CME Group Inc. $CME

Posted by ABMN Staff on Jul 25th, 2026

Bank of Nova Scotia decreased its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 28.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 236,348 shares of the financial services provider’s stock after selling 95,862 shares during the quarter. Bank of Nova Scotia’s holdings in CME Group were worth $69,802,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the business. Asset Dedication LLC boosted its stake in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the last quarter. Whipplewood Advisors LLC increased its stake in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 83 shares in the last quarter. FNY Investment Advisers LLC bought a new position in CME Group in the 4th quarter worth $27,000. Elkhorn Partners Limited Partnership bought a new position in CME Group in the 4th quarter worth $27,000. Finally, Hilton Head Capital Partners LLC purchased a new position in CME Group during the fourth quarter valued at $28,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

CME Group stock opened at $255.31 on Friday. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50-day moving average price of $254.13 and a 200-day moving average price of $281.22. The firm has a market capitalization of $92.51 billion, a PE ratio of 21.65, a price-to-earnings-growth ratio of 3.16 and a beta of 0.25.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the prior year, the company posted $2.96 EPS. As a group, equities research analysts forecast that CME Group Inc. will post 12.18 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on CME shares. Bank of America lifted their price objective on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Barclays reduced their price objective on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Piper Sandler decreased their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Finally, UBS Group dropped their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a report on Monday, July 6th. Eleven analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $291.81.

View Our Latest Stock Report on CME

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME Group’s Q2 results topped expectations, and the stock was reported higher on the earnings beat. US Stock Market: CME shares jump 6% after Q2 profit beats estimates; strong hedging demand boosts results
Positive Sentiment: Analysts noted strong fundamentals and at least one rating upgrade following the earnings release, which can support investor confidence. CME Group: Q2 Earnings Results Lead To A Rating Upgrade
Neutral Sentiment: UBS reiterated a Hold rating and kept its $260 target, signaling solid fundamentals but limited upside at current valuation. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
Negative Sentiment: Bank of America and JPMorgan both maintained bearish/underweight views, even though they slightly raised price targets, highlighting ongoing caution about upside. Analyst price target updates
Negative Sentiment: Short-interest data showed no meaningful short position, so this headline is unlikely to be a real stock driver and does not change the core thesis.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.